We then compared our existing model to three different variations of mouse models of induced endometriosis in order to compare differences in bioluminescent signal, lesion histology, pain-related behaviour and response to a cogent therapy: Cetrorelix (GnRH antagonist). This evidence concerns the gene GNRH1 and endometriosis.